Skip to main content

Table 1 Clinical manifestations of initial presentation of MS patients. n, %

From: The relationship of HLA-G 14-bp insertion/deletion genetic polymorphism to the risk of multiple sclerosis and its clinical phenotypes

  Number Percentage
Motor manifestations
 Hemiparesis 15 31.2%
 Monoparesis 2 4.2%
 Paraparesis 5 10.4%
 Quadriparesis 1 2.1%
 Cerebellar ataxia 8 16.7%
 Total 31 64.6%
Visual manifestations
 Optic neuritis 10 20.8%
Sensory manifestations
 Superficial sensory impairment 1 2.1%
 Deep sensory impairment 3 6.2%
 Total 4 8.3%
Brain stem symptoms
 Trigeminal neuralgia 1 2.1%
 Diplopia (INO) 2 4.2%
 Total 3 6.3%
Multiple symptoms at onset
 Optic neuritis with weakness 5 10.4%
 Diplopia (INO) with weakness 1 2.1%
 Total* 6 12.5%
Recovery after first insult
 Complete 14 29.2%
 Incomplete 31 64.6%
 No recovery 3 6.3%
  1. INO internuclear ophthalmoplegia. *12.5% (n=6/48) of patients presented with more than one symptom at onset: five patients presented with optic neuritis and hemiparesis and one patient presented with diplopia due to internuclear ophthalmoplegia and monoparesis